Attached files
Exhibit 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Quarterly Report on Form 10-Q of Echo
Therapeutics, Inc. (the “Company”) for the quarter
ended September 30, 2016 as filed with the Securities and Exchange
Commission on the date hereof (the “Report”), I, Alan
W. Schoenbart, Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. §1350, as adopted pursuant to §906
of the Sarbanes-Oxley Act of 2002:
1. The Report fully
complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
2.
The information
contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the
Company.
/s/ Alan W.
Schoenbart
Alan W.
Schoenbart
Chief
Financial Officer
(Principal
Financial and Accounting Officer)
Date:
November 16, 2016